Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Renal damage in the metabolic syndrome (MetSx): Disorders implicated.

Joyce T, Chirino YI, Natalia MT, Jose PC.

Eur J Pharmacol. 2018 Jan 5;818:554-568. doi: 10.1016/j.ejphar.2017.11.032. Epub 2017 Nov 21. Review.

PMID:
29162432
2.

The metabolic syndrome and chronic kidney disease.

Zhang X, Lerman LO.

Transl Res. 2017 May;183:14-25. doi: 10.1016/j.trsl.2016.12.004. Epub 2016 Dec 9. Review.

3.

Metabolic syndrome and chronic kidney disease.

Singh AK, Kari JA.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):198-203. doi: 10.1097/MNH.0b013e32835dda78. Review.

PMID:
23340215
4.

Epidemiology and Clinical Research for Chronic Kidney Disease.

Ninomiya T.

Fukuoka Igaku Zasshi. 2016 Aug;107(8):141-7. Review. Japanese. No abstract available.

PMID:
29227062
5.

Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.

Mulè G, Castiglia A, Cusumano C, Scaduto E, Geraci G, Altieri D, Di Natale E, Cacciatore O, Cerasola G, Cottone S.

Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Review.

PMID:
27873229
6.

Association between metabolic syndrome and chronic kidney disease in a Chinese urban population.

Chen J, Kong X, Jia X, Li W, Wang Z, Cui M, Xu D.

Clin Chim Acta. 2017 Jul;470:103-108. doi: 10.1016/j.cca.2017.05.012. Epub 2017 May 10.

PMID:
28501388
7.

Kidney pathological changes in metabolic syndrome: a cross-sectional study.

Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK.

Am J Kidney Dis. 2009 May;53(5):751-9. doi: 10.1053/j.ajkd.2009.01.255. Epub 2009 Apr 1.

8.

Metabolic syndrome and chronic kidney disease: Current status and future directions.

Prasad GV.

World J Nephrol. 2014 Nov 6;3(4):210-9. doi: 10.5527/wjn.v3.i4.210. Review.

9.

Adipokines promote chronic kidney disease.

Rüster C, Wolf G.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv8-14. doi: 10.1093/ndt/gft191. Review.

PMID:
24179016
10.

The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.

Chalmers L, Kaskel FJ, Bamgbola O.

Adv Chronic Kidney Dis. 2006 Oct;13(4):352-64. Review.

PMID:
17045221
11.

Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.

Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD.

J Clin Endocrinol Metab. 2012 Apr;97(4):1268-76. doi: 10.1210/jc.2011-2658. Epub 2012 Feb 15.

PMID:
22337909
12.

[Obesity in metabolic syndrome, as well as kidney dysfunction].

Sadulaeva IA, Vasyuk YA, Trofimenko OS, Yushchuk EN, Ivanova SV, Shupenina EY, Nesterova EA.

Ter Arkh. 2016;88(10):93-98. doi: 10.17116/terarkh201688693-98. Russian.

PMID:
28635857
13.

Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009.

Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE.

MEDICC Rev. 2011 Oct;13(4):14-22.

14.

Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus.

Spatola L, Ferraro PM, Gambaro G, Badalamenti S, Dauriz M.

Metabolism. 2018 Jun;83:225-233. doi: 10.1016/j.metabol.2018.02.008. Epub 2018 Mar 3. Review.

PMID:
29510180
15.

Retrospective analysis of renal histology in asymptomatic patients with probable chronic kidney disease of unknown aetiology in Sri Lanka.

Wijetunge S, Ratnatunga NV, Abeysekera DT, Wazil AW, Selvarajah M, Ratnatunga CN.

Ceylon Med J. 2013 Dec;58(4):142-7. doi: 10.4038/cmj.v58i4.6304.

16.

Childhood Obesity and the Metabolic Syndrome.

Nehus E, Mitsnefes M.

Pediatr Clin North Am. 2019 Feb;66(1):31-43. doi: 10.1016/j.pcl.2018.08.004. Review.

PMID:
30454749
17.

Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.

Eirin A, Zhu XY, Puranik AS, Tang H, McGurren KA, van Wijnen AJ, Lerman A, Lerman LO.

Kidney Int. 2017 Jul;92(1):114-124. doi: 10.1016/j.kint.2016.12.023. Epub 2017 Feb 24.

18.

Obesity and insulin resistance as risk factors for chronic kidney disease.

Whaley-Connell A, Pavey BS, Afroze A, Bakris GL.

J Cardiometab Syndr. 2006 Summer;1(3):209-14; quiz 215-6. Review.

19.

Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.

Chan DT, Watts GF, Irish AB, Ooi EM, Dogra GK.

Am J Hypertens. 2013 Sep;26(9):1155-61. doi: 10.1093/ajh/hpt077. Epub 2013 Jun 4.

PMID:
23736110

Supplemental Content

Support Center